Biosimilars, a new frontier?
Biosimilars entering the scene of intravitreal injections
LEARN MOREBiosimilars entering the scene of intravitreal injections
LEARN MOREWhere are we now with the spread of these therapies for AMD to prevent blindness?
LEARN MOREData from a retrospective real world study highlights low incidence of proactive treatment of nAMD
LEARN MOREPersistent subretinal fluid associated with reduced risk of atrophy
LEARN MOREError